Kathryn Walker is the CEO of Revitalist Lifestyle and Wellness (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) which serves as a publicly traded company. She is one few entrepreneurial females in the publicly traded space of psychedelics.
Kathryn worked at a Level 1 Trauma Center in Tennessee for 9 years before attending anesthesia school at the University of North Carolina-Charlotte. She practiced anesthesia of all specialties for 8 years before opening the first Revitalist location in Knoxville TN.
Today Kathryn operates as a leading advocate for provider lead businesses as she continues to advance her comprehensive skill set by pursing her advanced degree in Psychiatric Nursing.
Kathryn A. Walker is a pioneering medical researcher and psychiatrist known for her groundbreaking work in the field of mental health, particularly in the area of ketamine treatments. With a deep passion for understanding and alleviating the burden of treatment-resistant mood disorders, Kathryn has dedicated her career to investigating the therapeutic potential of ketamine.
Through her relentless efforts, she has played a pivotal role in shedding light on ketamine’s efficacy in treating conditions like depression, anxiety, and PTSD. Her research has not only transformed the way we approach mental health care but has also provided hope to countless individuals who had previously found little relief from conventional treatments.
Kathryn A. Walker’s pioneering contributions continue to shape the landscape of mental health medicine and inspire new avenues of research in the pursuit of better mental well-being for all.